What You Should Know: – KēlaHealth announced their Series A round (combined seed and Series A) of $12.9M led by Sante Ventures and new innovation VC, Intuitive Ventures. – KēlaHealth, is a surgical intelligence engine that applies a dynamic cycle of patient-specific predictions, stratified interventions,… Read More »KēlaHealth Lands $12.9M to Expand AI-Powered Surgical Intelligence Platform
Sheba ARC Innovation Center What You Should Know: – Holy Name Medical Center based in New Jersey and Israel’s Sheba Medical Center, the largest medical center in the Middle East announced a strategic partnership to develop digital health and telehealth solutions, The Times of Israel… Read More »Holy Name, Sheba Medical Center Partner to Develop Digital Health Solutions
What You Should Know: – Amazon Web Services (AWS) and the Pittsburgh Health Data Alliance (PHDA) announce a collaboration to produce more accurate machine learning models for breast cancer screening and depression. – In work funded through the PHDA-AWS collaboration, a research team led by… Read More »AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models
The company announced Wednesday the FDA approval of its liquid biopsy test, the second to win an agency nod in less than a month, saying it would launch the product on Friday. The FDA acquired the first ever liquid biopsy companion diagnostic, Guardant Health’s Guardant360… Read More »Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval
Shots: The two companies will develop and launch precision medicine strategies for CV, renal, and metabolic diseases. The first stage in the collaboration will use KidneyIntelX to improve outcomes for patients with CKD and its complications, in coordination with the Mount Sinai Health System The… Read More »AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases
The Chicago-based startup company plans to use the funding to further growth of its product offering and integration with EHRs and genetic testing partners.
Health and care have been inexorably moving towards a new paradigm – one where the nature of the interactions are more personalised and require the person to be more active in their pursuit of reducing risks that have an adverse effect upon the development of… Read More »The age of precision in the post COVID-19 world
What You Should Know: The FDA and Syapse announce research collaboration expansion to address urgent public health challenges including supporting FDA’s goal of rapid understanding of COVID-19. As part of the research, Syapse is partnering with FDA’s Oncology Center of Excellence to investigate methods to… Read More »FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer
What You Should Know: – Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020. – Deal expected to close in 1H 2021. – Varian Medical will maintain its brand name and operate “independently” – Siemens AG will… Read More »M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical
The new report, from the University of Pittsburgh Medical Center’s Center for Connected Medicine, surveyed 101 representatives of hospitals and healthcare systems. Nine out of 10 respondents said they were providing genomic or genetic testing or planning to.
Delivering on the promise of precision cancer medicine and why it matters even more during a pandemic
While many of us have avoided exposure to Covid-19 by sheltering in place, patients with […]
Read about new developments from healthcare startups including HealCo, Eikonoklastes, Sidecar Health and more.
Hackensack Meridian Health… read more
A Q&A with executives from Seven Bridges, a bioinformatics analysis business, highlights the company’s work in the precision medicine sector.
What You Should Know: – Fenway Health has been selected as the pilot site to participate in the Advancing Standards for Precision Medicine (ASPM) project. – The ASPM project is focused on how healthcare providers can systematically identify the socio-economic factors that may impact the… Read More »HHS Taps Fenway Health as Pilot Site for Precision Medicine Project
Electronic health record (EHR) systems store incredibly rich data about individual patients, but historically, individuals have been unable to access this information easily and share it for research. However, use of patients’ data could accelerate scientific discovery and progress toward precision medicine. Permitting patients to… Read More »Empowering Patients to Advance Precision Medicine, One EHR at a Time
Genomic data—information about the complete set of genes that make up each individual—have the potential to revolutionize healthcare and usher in a new era of precision medicine and scientific discovery. However, there is currently no standard way of presenting genomic data, and the standards for… Read More »Clinical Genomics Data for Precision Medicine